Aug 17 (Reuters) - A U.S. judge said on Tuesday that he would rule as soon as possible on a request to block the sale of a generic version of Sanofi-Aventis' (SASY.PA) blood thinner drug being marketed by Novartis AG's (NOVN.VX) Sandoz unit and Momenta Inc (MNTA.O).
Sanofi had argued that the FDA wrongly approved the generic medicine in July, stating that health regulators had failed to follow its procedures as well as ensure the generic version by Sandoz had the same active ingredient as its drug, known as Lovenox and used to treat blood clots.
Sanofi sought a preliminary injunction blocking the FDA's decision.
U.S. Judge Emmet Sullivan said he would "issue an appropriate decision as soon as I can," but gave no specific timetable for doing so. (Reporting by Jeremy Pelofsky, editing by Lisa Von Ahn)
Sounds like you have done this well. More power to ya.
I have not done as well and am long at about 17.50.
But I do think that MNTA will go much higher if TEVA does not get approval.
The law suit is noise and IMO will not stop the sales of generic Lovenox.
He doesn't want to show any partialty with the FDA and Momenta. He may drag this out till after labor day at the latest and than say Sanofi has no grounds to file this lawsuit, and he will dismiss the lawsuit without prejudice.